/
Immunology
Allergic Asthma
10
Pipeline Programs↗
6
Active Trials↗
16
Companies Involved↗
Allergic Asthma is an early-stage landscape with 10 programs across 16 companies. The most active players are Oneness Biotech Co., Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical8
Phase 1
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
68
clinical trials
Completed47 · 69%
Terminated8 · 12%
Recruiting4 · 6%
Withdrawn4 · 6%
Unknown status3 · 4%
Active, not recruiting1 · 1%
Other1 · 1%
Clinical Trials
Trial Activity
68 trials
Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma
Recruiting·FFraunhofer-Institute of Toxicology and Experimental Medicine·Preclinical·NCT06317909·15 enrolled
A Clinical Study of Omalizumab in the Treatment of Allergic Asthma(ESSENCE)
Recruiting·TThe First Affiliated Hospital with Nanjing Medical University·N/A·NCT06348407·300 enrolled
A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma
Completed·—·Phase 3·NCT04699604·55 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)